Notice for South Dakota Prescription Drug Monitoring Program (PDMP) effective February 1, 2023.
The South Dakota Board of Pharmacy will discontinue funding for integrated access to the Prescription Drug Monitoring Program (PDMP) and NarxCare effective February 1, 2023.
If you have a current agreement for PDMP access in South Dakota, license fees for integrated access and NarxCare reports will apply for continued service beyond February 1, 2023.